Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Barbara Malave"'
Autor:
Berta Piqué, Karla Peña, Francesc Riu, Johana C. Acosta, Laura Torres-Royo, Barbara Malave, Pablo Araguas, Rocío Benavides, Gabriel de Febrer, Jordi Camps, Jorge Joven, Meritxell Arenas, David Parada
Publikováno v:
Journal of Clinical Medicine
Volume 12
Issue 3
Pages: 798
Volume 12
Issue 3
Pages: 798
Several studies have shown that the plasma RNA of SARS-CoV-2 seems to be associated with a worse prognosis of COVID-19. In the present study, we investigated plasma RNA in COVID-19 patients treated with low-dose radiotherapy to determine its prognost
Autor:
Andrea Jiménez-Franco, Juan Manuel Jiménez-Aguilar, Marta Canela-Capdevila, Raquel García-Pablo, Helena Castañé, Cristian Martínez-Navidad, Pablo Araguas, Bárbara Malavé, Rocío Benavides-Villarreal, Johana C. Acosta, Alina Iuliana Onoiu, Navita Somaiah, Jordi Camps, Jorge Joven, Meritxell Arenas
Publikováno v:
Biomedicines, Vol 12, Iss 10, p 2196 (2024)
Background/Objectives: The management of early breast cancer (BC) includes surgery, followed by adjuvant radiotherapy, chemotherapy, hormone therapy, or immunotherapy. However, the influence of these interventions in metabolic reprogramming remains u
Externí odkaz:
https://doaj.org/article/6aaf45b5ff4f4750a32b51aa16b5e47c
Autor:
Elisabet Rodríguez-Tomàs, Meritxell Arenas, Gerard Baiges-Gaya, Johana Acosta, Pablo Araguas, Bárbara Malave, Helena Castañé, Andrea Jiménez-Franco, Rocío Benavides-Villarreal, Sebastià Sabater, Rosa Solà-Alberich, Jordi Camps, Jorge Joven
Publikováno v:
Antioxidants, Vol 11, Iss 12, p 2394 (2022)
Radiotherapy (RT) is part of the standard treatment of breast cancer (BC) because of its effects on relapse reduction and survival. However, response to treatment is highly variable, and some patients may develop disease progression (DP), a second pr
Externí odkaz:
https://doaj.org/article/bff6ecfbf4ca4cad818ba5c6ae1f13ae
Autor:
Elisabet Rodríguez-Tomàs, Johana C. Acosta, Laura Torres-Royo, Gabriel De Febrer, Gerard Baiges-Gaya, Helena Castañé, Andrea Jiménez, Carlos Vasco, Pablo Araguas, Junior Gómez, Bárbara Malave, Miguel Árquez, David Calderón, Berta Piqué, Manel Algara, Ángel Montero, Josep M. Simó, Xavier Gabaldó-Barrios, Sebastià Sabater, Jordi Camps, Jorge Joven, Meritxell Arenas
Publikováno v:
Antioxidants, Vol 11, Iss 6, p 1184 (2022)
The aim of our study was to investigate the changes produced by low-dose radiotherapy (LDRT) in the circulating levels of the antioxidant enzyme paraoxonase-1 (PON1) and inflammatory markers in patients with COVID-19 pneumonia treated with LDRT and t
Externí odkaz:
https://doaj.org/article/37f49139b7144f4e8ceb98bd6c843601